Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia
Authors:
- José A. CasadoJCJosé A. Casado
- Antonio ValeriAVAntonio Valeri
- Rebeca Sanchez-DomínguezRSRebeca Sanchez-Domínguez
- Paula VelaPVPaula Vela
- Susana NavarroSNSusana Navarro
- Omaira AlberquillaOAOmaira Alberquilla
- Helmut HanenbergHHHelmut Hanenberg
- Roser PujolRPRoser Pujol
- Jordi MinguillónJMJordi Minguillón
- Jordi SurrallésJordi Surrallés
Open Access
- 1 August 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (15)
Abstract
Fanconi anemia (FA) is the most prevalent inherited bone marrow failure (BMF) syndrome. Nevertheless, the pathophysiological mechanisms of BMF in FA have not been fully elucidated. Since FA cells are defective in DNA repair, we hypothesized that FA hematopoietic stem and progenitor cells (HSPCs) might express DNA damage–associated stress molecules such as natural killer group 2 member D ligands (NKG2D-Ls). These ligands could then interact with the activating NKG2D receptor expressed in cytotoxic NK or CD8+ T cells, which may result in progressive HSPC depletion. Our results indeed demonstrated upregulated levels of NKG2D-Ls in cultured FA fibroblasts and T cells, and these levels were further exacerbated by mitomycin C or formaldehyde. Notably, a high proportion of BM CD34+ HSPCs from patients with FA also expressed increased levels of NKG2D-Ls, which correlated inversely with the percentage of CD34+ cells in BM. Remarkably, the reduced clonogenic potential characteristic of FA HSPCs was improved by blocking NKG2D–NKG2D-L interactions. Moreover, the in vivo blockage of these interactions in a BMF FA mouse model ameliorated the anemia in these animals. Our study demonstrates the involvement of NKG2D–NKG2D-L interactions in FA HSPC functionality, suggesting an unexpected role of the immune system in the progressive BMF that is characteristic of FA.Keywords
Funding Information
- Ministerio de Ciencia e Innovación y Competitividad y Fondo Europeo de Desarrollo Regional (SAF2015-68073-R,SAF2015-64152-R,, RTI2018-097125-B-I00)
- Next Generation EU, Plan de Recuperación Transformación y Resilencia, (RD12/0019/0023)
- Programs of the European Commission (HEALTHF5-2012-305421, EUROFANCOLEN)
- Ministerio de Sanidad, Servicios Sociales e Igualdad (EC11/060, EC11/550)
- Comunidad de Madrid (AvanCell,B2017/BMD-3692)
- R.T.-R. is supported by a postdoctoral fellowship from the Asociación Española Contra el Cáncer (AECC). (No fund number)
This publication has 50 references indexed in Scilit:
- Fanconi anemia signaling network regulates the spindle assembly checkpointJournal of Clinical Investigation, 2013
- Genetic Associations in Acquired Immune-Mediated Bone Marrow Failure Syndromes: Insights in Aplastic Anemia and Chronic Idiopathic NeutropeniaJournal of Immunology Research, 2012
- Naive, Effector and Memory CD8 T-cell Trafficking: Parallels and DistinctionsImmunotherapy, 2011
- Spontaneous abrogation of the G2 DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patientsJournal of Clinical Investigation, 2011
- Gravity sedimentation of granulocytapheresis concentrates with hydroxyethyl starch efficiently removes red blood cells and retains neutrophilsTransfusion, 2010
- NKG2D‐mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromesBritish Journal of Haematology, 2009
- Aberrant activation of stress-response pathways leads to TNF-α oversecretion in Fanconi anemiaBlood, 2008
- Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysisBlood, 2007
- A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research NetworkJournal of Medical Genetics, 2006
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptorNature, 2005